Walmart will launch its own private brand insulin for people with diabetes as the battle for U.S. prescriptions with pharmacy rivals Amazon, Walgreens and CVS Health intensifies.
The move to offer a lower cost analog insulin, which could tap a market of more than 34 million Americans with diabetes, is the latest effort of the retail giant to expand deeper into pharmacy and outpatient healthcare services.
Walmart earlier this year offered a new drug discount program for employers, is launching its own telehealth services and has been offering more outpatient care via healthcare “super centers.” It’s an evolution for the retailer that began more than a decade ago when Walmart grabbed headlines for rolling out hundreds of generic prescriptions for just $4.
Source: Forbes
Omni Talk is the retail blog for retailers, written by retailers. Chris Walton and Anne Mezzenga founded Omni Talk in 2017 and have quickly turned it into one of the fastest growing blogs in retail. 
